Myriad Stymies Cancer Answers by Impeding Data Sharing

Tory Galloway thought her negative result on a widely-used test sold by Myriad Genetics Inc. cleared her DNA as a cause for her fallopian tube cancer.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.